Delayed
OTC Markets
09:30:00 2024-05-21 EDT
|
5-day change
|
1st Jan Change
|
0.000001
USD
|
0.00%
|
|
0.00%
|
0.00%
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Capitalization
1 |
8.767
|
17.5
|
41.39
|
0.3367
|
3.372
|
3.702
|
Enterprise Value (EV)
1 |
9.181
|
18.11
|
41.57
|
2.336
|
4.726
|
5.047
|
P/E ratio
|
-0.35
x
|
-13.1
x
|
-7.66
x
|
-0.03
x
|
-0.18
x
|
-8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
92,635,488
x
|
12,651,446
x
|
-
|
EV / Revenue
|
-
|
-
|
-
|
642,755,433
x
|
17,729,936
x
|
-
|
EV / EBITDA
|
-2.72
x
|
-5.41
x
|
-11.3
x
|
-0.54
x
|
-1.98
x
|
-1.89
x
|
EV / FCF
|
1.05
x
|
-2.76
x
|
111
x
|
1.79
x
|
-18
x
|
-2.93
x
|
FCF Yield
|
95.5%
|
-36.3%
|
0.9%
|
56%
|
-5.54%
|
-34.1%
|
Price to Book
|
-0.93
x
|
-4.86
x
|
-10.5
x
|
-0.09
x
|
-0.51
x
|
-0.85
x
|
Nbr of stocks (in thousands)
|
974
|
2,822
|
4,096
|
6,735
|
16,862,482
|
18,507,684
|
Reference price
2 |
9.000
|
6.200
|
10.11
|
0.0500
|
0.000200
|
0.000200
|
Announcement Date
|
17-03-31
|
18-03-28
|
19-03-27
|
20-03-24
|
21-08-02
|
22-03-31
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net sales
|
-
|
-
|
-
|
0.003635
|
0.2666
|
-
|
EBITDA
1 |
-3.37
|
-3.347
|
-3.692
|
-4.296
|
-2.387
|
-2.67
|
EBIT
1 |
-3.371
|
-3.349
|
-3.695
|
-4.301
|
-2.392
|
-2.671
|
Operating Margin
|
-
|
-
|
-
|
-118,327.57%
|
-897.44%
|
-
|
Earnings before Tax (EBT)
1 |
-12.46
|
-1.032
|
-4.45
|
-9.459
|
-8.772
|
-0.4517
|
Net income
1 |
-12.46
|
-1.033
|
-4.451
|
-9.461
|
-8.772
|
-0.4517
|
Net margin
|
-
|
-
|
-
|
-260,269.19%
|
-3,290.52%
|
-
|
EPS
2 |
-25.67
|
-0.4744
|
-1.319
|
-1.861
|
-0.001117
|
-0.000025
|
Free Cash Flow
1 |
8.764
|
-6.575
|
0.3761
|
1.307
|
-0.2619
|
-1.721
|
FCF margin
|
-
|
-
|
-
|
35,964.54%
|
-98.24%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17-03-31
|
18-03-28
|
19-03-27
|
20-03-24
|
21-08-02
|
22-03-31
|
Fiscal Period: December |
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
---|
Net Debt
1 |
0.41
|
0.62
|
0.18
|
2
|
1.35
|
1.35
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.1228
x
|
-0.1846
x
|
-0.0485
x
|
-0.4654
x
|
-0.567
x
|
-0.504
x
|
Free Cash Flow
1 |
8.76
|
-6.57
|
0.38
|
1.31
|
-0.26
|
-1.72
|
ROE (net income / shareholders' equity)
|
219%
|
15.2%
|
117%
|
174%
|
129%
|
8.2%
|
ROA (Net income/ Total Assets)
|
-508%
|
-434%
|
-651%
|
-574%
|
-677%
|
-15,389%
|
Assets
1 |
2.454
|
0.2378
|
0.6839
|
1.649
|
1.295
|
0.002935
|
Book Value Per Share
2 |
-9.720
|
-1.270
|
-0.9600
|
-0.5400
|
-0
|
-0
|
Cash Flow per Share
2 |
0.0100
|
0
|
0.0900
|
0.0200
|
-
|
-
|
Capex
|
-
|
0
|
0.01
|
0.01
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
369.99%
|
-
|
-
|
Announcement Date
|
17-03-31
|
18-03-28
|
19-03-27
|
20-03-24
|
21-08-02
|
22-03-31
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 18.48K | | +18.38% | 85.14B | | -27.39% | 72.06B | | +2.75% | 27.07B | | -9.71% | 17.43B | | -1.96% | 16.98B | | +3.66% | 16.02B | | +8.80% | 13.87B | | +72.65% | 13.06B | | +73.21% | 12.79B |
Other Healthcare Facilities & Services
|